Mitochondrial Function and Aging: What Changes Inside Your Cells

Edited by Samael A. Tejada, Founder & Editor-in-Chief

The short answer: mitochondrial function declines with age. Compared with young tissue, older muscle, brain, and immune cells typically produce energy less efficiently, carry more mutations in their mitochondrial DNA, and clear out damaged mitochondria more slowly. Scientists formally count mitochondrial dysfunction among the hallmarks of aging. But the decline is neither uniform nor one-way: in study after study, exercise training restores much of the mitochondrial capacity that older adults had lost — which is why training, not any supplement, remains the best-established response to aging mitochondria.

This guide walks through what actually changes inside your cells over a lifetime, how much of aging mitochondria cause versus merely reflect, and which interventions have human evidence behind them — graded claim by claim.

What actually changes in mitochondria as we age?

Less capacity. Older skeletal muscle typically contains mitochondria that respire less per unit and, in sedentary people, fewer of them. The deficit shows up as slower recovery, earlier fatigue, and reduced aerobic capacity.

More DNA damage. Mitochondria carry their own small genome, and it accumulates point mutations and deletions across a lifetime — most densely in energy-hungry, long-lived tissues like brain and muscle. Individual mutated genomes can clonally expand inside single cells until that cell's energy production fails.

Slower cleanup. Healthy cells constantly retire worn-out mitochondria through mitophagy and build fresh ones (biogenesis). With age, mitophagy slows — recent work in human neurons shows the lysosomes that digest old mitochondria declining in step — so damaged units linger, leaking reactive oxygen species and inflammatory signals. Our research coverage of that neuron-aging work is here.

Changed membranes and fuel handling. The signature mitochondrial fat cardiolipin is remodeled with age, and the NAD+ pool that feeds the respiratory chain shrinks — tying this story directly to NAD+ decline. Taken together, the 2023 update of the influential Hallmarks of Aging framework lists mitochondrial dysfunction as one of aging's core processes. Established

Do failing mitochondria cause aging, or just reflect it?

Honest answer: both, in proportions still argued about. The strongest causal proof comes from 'mutator' mice engineered with a faulty mitochondrial DNA polymerase: they accumulate mtDNA mutations rapidly and develop strikingly premature aging — hair loss, osteoporosis, cardiac enlargement, early death (Trifunovic et al., Nature, 2004). That experiment proves mtDNA damage can drive aging-like decline.

The catch is scale. Those mice carry mutation burdens far beyond anything measured in normally aged human tissue, and the field has largely moved past the older theory that reactive oxygen species from mitochondria are the master driver — mutator mice aged fast without proportionally increased oxidative damage. Today's working model treats mitochondrial decline as one hallmark among a dozen, feeding and fed by inflammation, senescence, and stem-cell exhaustion. Anyone who tells you aging is simply 'your mitochondria wearing out' is selling a simpler story than the science supports. Contested — the causal share

Where does the age-related decline show up first?

Muscle is where the decline is best documented and most felt: mitochondrial loss tracks with sarcopenia — the age-related loss of muscle mass and strength — and with slower walking speed and fatigability in older cohorts.

Brain tissue, with its extreme energy demands and non-dividing neurons, accumulates mtDNA deletions heavily; mitochondrial failure is a recurring feature of Parkinson's and Alzheimer's research, though cause and effect remain entangled.

The immune system ages mitochondrially too: older immune cells shift metabolism in ways that favor the chronic, sterile inflammation researchers call inflammaging — which itself damages mitochondria elsewhere. We covered that two-way street in our inflammaging review. Metabolic tissues follow: mitochondrial capacity in muscle predicts insulin sensitivity, linking cellular aging to type 2 diabetes risk.

What can you do that measurably helps aging mitochondria?

Exercise — the standout. In a landmark trial, twelve weeks of high-intensity interval training increased mitochondrial capacity by about 49 percent in young adults and about 69 percent in older adults, partially reversing age-related transcriptional decline in muscle (Robinson et al., Cell Metabolism, 2017). Aerobic and resistance training both work through overlapping pathways — our top five actions guide ranks them. Established

Sleep and circadian regularity. Mitochondria run on a daily clock, and chronic circadian disruption degrades their function in controlled studies; consistent sleep timing is the practical lever (see our sleep and circadian guide). Not smoking protects respiration directly, and adequate protein supports the muscle tissue where most mitochondria live.

Notice what is absent from the proven list: any pill. That is a statement about the current evidence, not about what future trials may find.

What about longevity drugs and peptides aimed at mitochondria?

Urolithin A — a gut-derived compound that stimulates mitophagy — has the most respectable early record: randomized trials in older adults report improved muscle endurance and mitophagy-related markers. Real, but modest and still early. Preliminary

NAD+ boosters (NR, NMN) reliably raise NAD+ levels, but functional benefits in healthy people are unproven — see our NAD+ guide. Elamipretide (SS-31), a peptide that targets the mitochondrial membrane fat cardiolipin, has a beautiful mechanism and a disappointing trial record, missing primary endpoints in mitochondrial disease and heart failure studies. Contested MOTS-c and other mitochondrial-derived peptides remain at the preclinical or earliest-clinical stage. Preliminary to Absent in humans

What is the honest bottom line?

Aging mitochondria are real, measurable, and partly actionable. The changes — lost capacity, accumulated mtDNA damage, sluggish cleanup — are established; their exact share of responsibility for aging is still debated; and the one intervention that repeatedly restores function in older humans is exercise, with sleep regularity behind it. Compounds aimed at aging mitochondria are worth watching and, in urolithin A's case, genuinely promising — but as of today none has earned the certainty with which they are marketed. The cells' powerhouses do age. They also, remarkably, respond when you ask more of them.

Where the evidence stands

• Established: Mitochondrial dysfunction is one of the hallmarks of aging (López-Otín et al., Cell, 2023, updated framework).
• Established: mtDNA mutations and deletions accumulate with age in human tissues, especially brain and muscle.
• Established: Exercise training substantially restores mitochondrial capacity in older muscle — in one trial, older adults gained about 69 percent in mitochondrial capacity with interval training (Robinson et al., Cell Metabolism, 2017).
• Contested: How much of normal human aging is caused by mtDNA mutations: mutator mice prove mutations can drive aging-like decline, but typical human mutation burdens are far lower.
• Preliminary: Urolithin A improved muscle-endurance measures in randomized trials in older adults, consistent with improved mitophagy.
• Contested: Elamipretide (SS-31), a mitochondria-targeted peptide: multiple trials have missed their primary endpoints despite a strong mechanistic rationale.